Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Ранг среди акций #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Цена акции
$5.59
Последняя синхронизация: 2026-09-02
Рыночная капитализация
$205.21M
Изменение (1 день)
6.27%
Изменение (1 год)
86.33%
Страна
US
Торговля Armata Pharmaceuticals, Inc. (ARMP)

Категория

Коэффициент P/S для Armata Pharmaceuticals, Inc. (ARMP)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Armata Pharmaceuticals, Inc., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Armata Pharmaceuticals, Inc. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
10.95 -
US
12.19 -
NL
24.99 -
US
3.75 -
AU
- -
CH